awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38946563-160A4E42-1B79-463C-92DF-76FDF0E36BD1
Q38946563-160A4E42-1B79-463C-92DF-76FDF0E36BD1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-160A4E42-1B79-463C-92DF-76FDF0E36BD1
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.
P2860
Q38946563-160A4E42-1B79-463C-92DF-76FDF0E36BD1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-160A4E42-1B79-463C-92DF-76FDF0E36BD1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3dc1377da6ef5745b3194a8cb59bea1150c24ea4
P2860
Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides-harmonized terminology and tactical recommendations.